This suggests that MEG3 inhibits cervical cancer progression by regulating PI3K/AKT/Bcl-2/Bax/P21 and PI3K/AKT/MMP-2/9 signaling pathways in cervical cancer (Fig. 1c). The gene discussed is BCL2; the disease is cervical carcinoma.